NCT05149560View on ClinicalTrials.gov

Ticagrelor Monotherapy After Stenting

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 4, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Ticagrelor 90mg

All patients will be prescribed ticagrelor as monotherapy

Trial Locations (1)

41345

Kardiologen, Gothenburg

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

lead

Vastra Gotaland Region

OTHER_GOV